Can leucovorin treat autism? History says, probably not

January 23, 2026 - 06:08

A surge in demand is being reported for the prescription vitamin leucovorin, driven by parents of autistic children seeking new treatment options. This interest follows promotional efforts from federal health officials, yet medical experts are urging significant caution due to a stark lack of supporting evidence.

Leucovorin, a form of folate, is medically approved for specific uses like counteracting toxic effects from certain chemotherapy drugs. Its proposed application for autism spectrum disorder is based on a hypothesis involving cerebral folate deficiency. However, the history of its investigation for this purpose reveals a troubling pattern of insufficient data.

Major medical institutions and specialists consistently point out that robust, large-scale clinical trials have not been conducted to demonstrate leucovorin's efficacy in treating core symptoms of autism. While small, preliminary studies have shown mixed results, they are not considered conclusive by the broader scientific community. This creates a concerning gap between public hope and clinical proof.

Doctors emphasize that pursuing unproven treatments can lead to financial strain, false hope, and potential delays in accessing established behavioral and educational interventions that have demonstrated benefits. The situation underscores the critical need for more rigorous research to provide clear answers for families navigating complex treatment landscapes.